Dynorphin A (1-13)

Product Overview

Dynorphin A (1-13) is a highly specialized bioactive peptide sequence utilized extensively in pharmaceutical research and biochemical studies. As an endogenous opioid peptide, it serves as a critical tool for investigating opioid receptor interactions and neurological pathways. Our manufacturing process ensures exceptional purity and consistency, making it suitable for rigorous laboratory environments and developmental projects.

This product is synthesized using advanced solid-phase peptide synthesis techniques, adhering to strict quality control protocols. Each batch undergoes comprehensive analytical testing to verify structural integrity and purity levels. We prioritize compliance and safety, providing this material strictly for research and development purposes within the pharmaceutical and biotechnology sectors.

Chemical Properties and Specifications

The chemical structure of Dynorphin A (1-13) consists of a specific sequence of amino acids that define its biological activity. Maintaining the correct stereochemistry and sequence order is paramount for its performance in research applications. Our facility employs high-performance liquid chromatography (HPLC) and mass spectrometry to validate each lot.

Industrial and Research Applications

In the realm of pharmaceutical development, this peptide is instrumental for studying analgesic mechanisms and receptor binding affinities. Researchers utilize Dynorphin A (1-13) to explore potential therapeutic pathways related to pain management and neurological function. It serves as a reference standard in various bioassays and helps in the validation of new opioid receptor ligands.

• Neurological research and receptor binding studies
• Pharmaceutical intermediate for drug development
• Biochemical standard for assay calibration
• Investigation of endogenous opioid systems

While historical data suggests potential interactions with morphine requirements in clinical settings, our product is designated for preclinical research only. It supports the development of novel therapeutics by providing a reliable source of high-quality peptide material for in vitro and animal model studies.

Quality Assurance and Storage

We understand the importance of stability in peptide products. Our Dynorphin A (1-13) is packaged in sealed containers to prevent moisture absorption and degradation. Proper storage conditions are essential to maintain the specified purity over time. We recommend storing the material in a cool, ventilated environment away from direct light and heat sources.

Every shipment includes a Certificate of Analysis (COA) detailing the specific test results for that batch. Our global manufacturing network ensures consistent supply chains, allowing researchers to plan long-term projects without interruption. For large-scale requirements, we offer flexible packaging solutions tailored to customer needs, ensuring safe transport and handling.